Clinical Trial Update: Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated whether dapagliflozin affects the pharmacokinetics of warfarin and digoxin in healthy subjects. The study is complete.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DIGOXIN (Digoxin)
• Dapagliflozin (dapagliflozin)
• Warfarin (warfarin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED